| Kürzel | Analyse | Material | |
|---|---|---|---|
| PROTHIPEN | Prothipendyl | MATERIAL: Serum; METHODE: LC-MS | |
| PROTSF | Protein S (frei) | MATERIAL: Citrat, METHODE: chromogenes Substrat | |
| PROTUQ | Protein Kreatinin Ratio i.H. | ||
| PSA | PSA Screening | MATERIAL: Serum/Vollblut, METHODE: CMIA | |
| PSAAP | Pseud.aeru. Alk. Protease IgG | MATERIAL: Serum, METHODE: EIA | |
| PSAEL | Pseud.aeru. Elastase IgG | MATERIAL: Serum, METHODE: EIA | |
| PSAEX | Pseud.aeru. Exotoxin IgG | MATERIAL: Serum, METHODE: EIA | |
| PSAFTU | PSA-frei (Tumormarker) | MATERIAL: Serum/Vollblut, METHODE: CMIA | |
| PSILOCYBH | Psilocybin (U) | MATERIAL: Spontanharn (10ml), METHODE: CEDIA | |
| PT | PT (Quick) | MATERIAL: Citrat, METHODE: Clotting | |
| PTAK | Anti Prothrombin Ak Scr. | MATERIAL: Serum/Vollblut METHODE: ELISA | |
| PTAKG | Anti Prothrombin Ak IgG | MATERIAL: Serum/Vollblut METHODE: ELISA | |
| PTAKM | Anti Prothrombin Ak IgM | MATERIAL: Serum/Vollblut METHODE: ELISA | |
| pTAU181 | pTAU 181 | MATERIAL: EDTA-Plasma, METHODE: immunologisch | |
| pTAU217 | pTAU 217 | MATERIAL: EDTA-Plasma, METHODE: immunologisch | |
| PTMUT | PT-Mutation 20210A | MATERIAL: EDTA; Methode: Gentest | |
| PTT | PTT | MATERIAL: Citrat, METHODE: Clotting | |
| PTTLA | aPTT (Lupus-Ak-sensitiv) | MATERIAL: Citrat, | |
| PV | Phosphor im Vollblut (EDTA) | MATERIAL: EDTA, METHODE: ICP-MS | |
| PYRUVAT | Pyruvat | MATERIAL: Fluorid-Blut, METHODE: photometrisch |